Xero Stock And 2 AI Shares Built On Recurring Software Revenue

Record current account surpluses in export heavy countries such as South Korea, helped by strong semiconductor shipments, show how central advanced chips have become to global trade. AI tools like ChatGPT live on that hardware and on the software and cloud platforms that support it. This article walks through three stocks from our AI Stocks screener so you can see how different parts of the AI stack fit together.

The three stocks below are just a starting sample from this AI stack, and the full screen surfaced 14 more companies with equally compelling narratives that are not covered in the article. To identify and analyze your own angles on the ChatGPT and AI theme, head straight into the Artificial Intelligence/ AI Stocks screener.

Aura Consolidated Group (ASX:AXQ)

Aura Consolidated Group (ASX:AXQ) runs a digital safety platform that bundles credit monitoring, identity theft protection, online privacy tools, antivirus, VPN and parental controls into one service for individuals, families and employees. The company generates all of its US$192 million in revenue from security software and services. Aura Consolidated Group currently carries a market cap of about A$697 million.

Investors looking at the AI and cybersecurity theme may find Aura Consolidated Group interesting because it is tying AI driven monitoring and alerts directly to everyday risks like identity theft, scams and child online safety. Revenue climbed 31.3% in the past year, yet the company is still reporting sizeable losses and has less than one year of cash runway, which makes execution over the next few years critical. The recent IPO and fresh leadership hires, including a new global CMO, add another layer to the story that could matter for growth minded investors who are comfortable with higher risk, early stage software stocks.

Revenue growth at Aura Consolidated Group is racing ahead of profits, which often hides important details. Get the full story on cash runway pressure, execution risk and product momentum in the 1 key reward and 3 important warning signs (2 are major!)

Build your own AI security shortlist

Aura Consolidated Group and the two other AI stocks in this article all came from a single screener, but your best ideas will often come from filters tailored to your own risk and return preferences. Use our flexible Screener to mix metrics like valuation, growth potential, balance sheet strength and risks into a custom watchlist, or tap into our ready made Investing Ideas for curated themes and stock collections.

Xero (ASX:XRO)

Xero provides cloud based accounting, payroll, payments and workflow tools for small businesses and their advisors, all delivered through its Xero platform and add ons like Planday, Hubdoc and AI enabled reporting in Syft. The business generated about NZ$2.8b in revenue in 2026, almost entirely from providing online solutions for small businesses and advisors, and carries a market cap of roughly A$12.9b. For investors, it sits at the intersection of software, payments and AI driven financial automation.

Xero is interesting if you care about how AI can make routine financial work disappear for small businesses rather than replace their accountants. Revenue reached around NZ$2.8b last year with very high gross margins. However, net margins have slipped from 10.8% to 6.1% and earnings fell in the most recent year even though 5 year growth has been strong. The stock trades on a rich valuation and has underperformed recently, while forecasts still point to fast earnings growth and analysts see upside based on cash flow estimates. At the same time, reliance on external borrowing and relatively low current returns on equity keep the risk side of the ledger alive, especially if AI features like JAX, XeroForce and the new Microsoft 365 and Anthropic integrations do not translate into the profit lift the market is watching for.

Revenue is rising, margins have slipped and Xero is still priced for big ambitions. See how that mix plays out in the analyst forecasts for Xero and where the real pressure point could emerge next

Echo IQ (ASX:EIQ)

Echo IQ (ASX:EIQ) focuses on AI based tools that help cardiologists spot structural heart disease such as aortic stenosis, diastolic dysfunction and heart failure. The company currently records about A$0.1 million in revenue from the development of artificial intelligence software and has a market cap of roughly A$1.1b.

Echo IQ sits at the very early revenue stage. Analysts expect very large revenue growth from this small base and see upside for the stock price, supported by fresh capital from a A$110 million follow on offering and a focus on US expansion. The flip side is sharp share price swings, a high P/B multiple, ongoing losses and funding that leans fully on external borrowing rather than customer deposits. For investors who can handle that risk mix, the Mayo Clinic collaboration and new healthcare experienced CFO indicate what this AI cardiology specialist could become if clinical data and commercial traction line up.

Echo IQ’s tiny revenue base and A$1.1b valuation make growth expectations hard to ignore. Get a clearer view of what analysts are actually pricing in with the analyst forecasts for Echo IQ

Seeking Fresh Alternatives Beyond AI?

Market momentum can shift fast and the most interesting breakout stories often get caught early while they are still flying under the radar for now. Do not delay. Act now.

• Spot income ideas with staying power by scanning for companies in the 4 dividend fortresses before yields drop and the strongest options get crowded out by income hunters.
• Hunt for resilient operators by sorting through the 10 resilient stocks with low risk scores and see which businesses still look steady while risk appetite jumps around.
• Track critical infrastructure stories by reviewing the 36 power grid technology and infrastructure stocks while these grid and electrification themes are still building and not fully priced in.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com